Listen to the Analyst call.. Do your own thinking Listen to the call
ttps://produceredition.webcasts.com/starthere.jsp?ei=1329530&tp_key=f0dc4775b3 Review the updated slide deck...
https://antibethera.com/wp-content/uploads/2020/06/Antibe-Investor-Presentation-June-2020.pdf If you are lazy here are the cliffs notes:
--- Timeline has not changed... proceeding to PH3
--- Partnership discussions are on track (summer)
--- The lower dose does not slow down their advancement into phase 3
--- WOMAC scores are solid - "listen to the CMO in the call on this"
--- Typical studies are for 12 weeks to see efficacy, 346 saw a solid efficacy increase in the two weeks
--- They will do a 12 week study next
-- The 150 mh dosage surprised them in a good way....
--- CMO (new) was there when Viox and Celebrax went thru FDA... might have learned a few things...